Treating gestational trophoblastic disease

Expert Opinion on Pharmacotherapy

Volumn 11, Issue 18, 2010, Pages 3027-3039

  Rodriguez, Noah ^a   Goldstein, Donald P ^a   Berkowitz, Ross S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Complete mole; Gestational trophoblastic disease; Gestational trophoblastic neoplasia; Molar pregnancy

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; HYDROXYUREA; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PACLITAXEL; VINBLASTINE; VINCRISTINE; VINCRISTINE SULFATE;

BREAST CANCER; CANCER REGRESSION; CANCER STAGING; CLINICAL TRIAL; COLON CANCER; DISEASE CLASSIFICATION; FERTILITY; HUMAN; HYDATIDIFORM MOLE; HYSTERECTOMY; LEUKEMIA; MELANOMA; METASTASIS; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SECOND CANCER; TROPHOBLASTIC TUMOR;

ANTINEOPLASTIC AGENTS; FEMALE; FERTILITY; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREGNANCY; RISK FACTORS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 78649254962     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.2010.512288     Document Type: Review

References (120)

1. Bagshawe KD. Risk and prognostic factors in trophoblastic neoplasia. Cancer 1976;38:1373-85
2. Goldstein DP, Berkowitz RS. Gestational trophoblastic neoplasms: clinical principles of diagnosis and management (Major problems in obstetrics and gynecology). (volume 14). Saunders, Philadelphia; 1982. p. xvi, 1301
3. Lurain JR. Advances in management of high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:451-9
4. Martin BH, Kim JH. Changes in gestational trophoblastic tumors over four decades. A Korean experience. J Reprod Med 1998;43:60-8
5. Berkowitz RS, Goldstein DP. Chorionic tumors. N Engl J Med 1996;335:1740-8
6. Elias KM, Goldstein D, Berkowitz R. Complete hydatidiform mole in women older than age 50. J Reprod Med 2010;55:208-12
7. Feltmate CM, Batorfi J, Fulop V, et al. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation. Obstet Gynecol 2003;101:732-6 (Pubitemid 36390063)
8. Wolfberg AJ, Feltmate C, Goldstein DP, et al. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy. Obstet Gynecol 2004;104:551-4
9. Wolfberg AJ, Growdon WB, Feltmate CM, et al. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy. Obstet Gynecol 2006;108:393-6
10. Lavie I, Rao GG, Castrillon DH, et al. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. Am J Obstet Gynecol 2005;192:1362-4
11. Kashimura Y, Kashimura M, Sugimori H, et al. Prophylactic chemotherapy for hydatidiform mole. Five to 15 years follow-up. Cancer 1986;58:624-9
12. Goldstein DP, Berkowitz RS. Prophylactic chemotherapy of complete molar pregnancy. Semin Oncol 1995;22:157-60
13. Kim DS, Moon H, Kim KT, et al. Effects of prophylactic chemotherapy for persistent trophoblastic disease in patients with complete hydatidiform mole. Obstet Gynecol 1986;67:690-4
14. Limpongsanurak S. Prophylactic actinomycin D for high-risk complete hydatidiform mole. J Reprod Med 2001;46:110-16
15. Kohorn EI. Negotiating a staging and risk factor scoring system for gestational trophoblastic neoplasia. A progress report. J Reprod Med 2002;47:445-50
16. McGrath S, Short D, Harvey R, et al. The management and outcome of women with post-hydatidiform mole 'low-risk' gestational trophoblastic neoplasia, but hCG levels in excess of 100 000 IU l (-1). Br J Cancer 2010;102:810-14
17. Hammond CB, Weed JC Jr, Currie JL. The role of operation in the current therapy of gestational trophoblastic disease. Am J Obstet Gynecol 1980;136:844-58
18. Lurain JR, Singh DK, Schink JC. Role of surgery in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med 2006;51:773-6
19. Mutch DG, Soper JT, Baker ME, et al. Role of computed axial tomography of the chest in staging patients with nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1986;68:348-52
20. Garner EI, Garrett A, Goldstein D, et al. Significance of chest computed tomography findings in the evaluation and treatment of persistent gestational trophoblastic neoplasia. J Reprod Med 2004;49:411-14
21. Dhillon T, Palmieri C, Sebire NJ, et al. Value of whole body 18FDG-PET to identify the active site of gestational trophoblastic neoplasia. J Reprod Med 2006;51:879-87
22. Bagshawe KD, Harland S. Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer 1976;38:112-18
23. Bakri Y, al-Hawashim N, Berkowitz R. CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor. J Reprod Med 2000;45:94-6
24. Berkowitz RS, Goldstein DP. Pathogenesis of gestational trophoblastic neoplasms. Pathobiol Annu 1981;11:391-411
25. Bagshawe KD, Noble MI. Cardio-respiratory aspects of trophoblastic tumours. Q J Med 1966;35:39-54
26. Jones WB, Wagner-Reiss KM, Lewis JL Jr. Intracerebral choriocarcinoma. Gynecol Oncol 1990;38:234-43
27. Bakri Y, Berkowitz RS, Goldstein DP, et al. Brain metastases of gestational trophoblastic tumor. J Reprod Med 1994;39:179-84
28. Cagayan MS, Lu-Lasala LR. Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: a 12-year review at the Philippine General Hospital. J Reprod Med 2006;51:785-92
29. Athanassiou A, Begent RH, Newlands ES, et al. Central nervous system metastases of choriocarcinoma. 23 years' experience at Charing Cross Hospital. Cancer 1983;52:1728-35
30. Liu TL, Deppe G, Chang QT, et al. Cerebral metastatic choriocarcinoma in the People's Republic of China. Gynecol Oncol 1983;15:166-70
31. Bakri YN, Subhi J, Amer M, et al. Liver metastases of gestational trophoblastic tumor. Gynecol Oncol 1993;48:110-13
32. Berkowitz RS, Goldstein DP, Bernstein MR. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 1986;23:111-18
33. Growdon WB, Wolfberg AJ, Goldstein DP, et al. Evaluating methotrexate treatment in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol 2009;112:353-7
34. Homesley HD. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease. J Reprod Med 1998;43:69-74
35. Osathanondh R, Goldstein DP, Pastorfide GB. Actinomycin D as the primary agent for gestational trophoblastic disease. Cancer 1975;36:863-6
36. Bagshawe KD, Dent J, Newlands ES, et al. The role of low-dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT). Br J Obstet Gynaecol 1989;96:795-802
37. Lurain JR. Treatment of gestational trophoblastic tumors. Curr Treat Options Oncol 2002;3:113-24
38. Osborne R, Gerulath A. What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med 2004;49:602-16
39. Petrilli ES, Twiggs LB, Blessing JA, et al. Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology Group. Cancer 1987;60:2173-6
40. Fulop V, Szigetvari I, Szepesi J, et al. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. J Reprod Med 2010;55:253-7
41. Roberts JP, Lurain JR. Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996;174:1917-23; discussion 1923-4
42. Rose PG, Piver MS. Alternating methotrexate and dactinomycin in nonmetastatic gestational trophoblastic disease. J Surg Oncol 1989;41:148-52
43. Osborne R, Filiaci VL, Schink JC, et al. A randomized phase III trial comparing weekly parenteral methotrexate and pulsed dactinomycin as primary management of low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group Study. Gynecol Oncol 2008;108:s2
44. Cole LA, Khanlian SA, Muller CY, et al. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol 2006;102:160-4
45. Feltmate CM, Genest DR, Goldstein DP, et al. Advances in the understanding of placental site trophoblastic tumor. J Reprod Med 2002;47:337-41
46. Papadopoulos AJ, Foskett M, Seckl MJ, et al. Twenty-five years' clinical experience with placental site trophoblastic tumors. J Reprod Med 2002;47:460-4
47. Palmer JE, Macdonald M, Wells M, et al. Epithelioid trophoblastic tumor: a review of the literature. J Reprod Med 2008;53:465-75
48. Rustin GJ, Newlands ES, Lutz JM, et al. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol 1996;14:2769-73
49. Rojas-Espaillat L, Houck KL, Hernandez E, et al. Fertility-sparing surgery for persistent gestational trophoblastic neoplasia in the myometrium: a case report. J Reprod Med 2007;52:431-4
50. Kim SJ, Bae SN, Kim JH, et al. Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71:247-53
51. Curry SL, Blessing JA, DiSaia PJ, et al. A prospective randomized comparison of methotrexate, dactinomycin, and chlorambucil versus methotrexate, dactinomycin, cyclophosphamide, doxorubicin, melphalan, hydroxyurea, and vincristine in 'poor prognosis' metastatic gestational trophoblastic disease: a Gynecologic Oncology Group study. Obstet Gynecol 1989;73:357-62
52. DuBeshter B, Berkowitz RS, Goldstein DP, et al. Metastatic gestational trophoblastic disease: experience at the New England Trophoblastic Disease Center, 1965 to 1985. Obstet Gynecol 1987;69:390-5
53. Gordon AN, Gershenson DM, Copeland LJ, et al. High-risk metastatic gestational trophoblastic disease: further stratification into two clinical entities. Gynecol Oncol 1989;34:54-6
54. Bolis G, Bonazzi C, Landoni F, et al. EMA/CO regimen in high-risk gestational trophoblastic tumor (GTT). Gynecol Oncol 1988;31:439-44
55. Bower M, Newlands ES, Holden L, et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-43
56. Kim SJ, Bae SN, Kim JH, et al. Effects of multiagent chemotherapy and independent risk factors in the treatment of high-risk GTT - 25 years experiences of KRI-TRD. Int J Gynaecol Obstet 1998;60(Suppl 1):S85-96
57. Xiang Y, Sun Z, Wan X, et al. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor. J Reprod Med 2004;49:443-6 (Pubitemid 38781419)
58. Bagshawe KD. Treatment of high-risk choriocarcinoma. J Reprod Med 1984;29:813-20
59. Lurain JR, Singh DK, Schink JC. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med 2006;51:767-72
60. Soper JT, Evans AC, Clarke-Pearson DL, et al. Alternating weekly chemotherapy with etoposide-methotrexatedactinomycin/cyclophosphamidevincristine for high-risk gestational trophoblastic disease. Obstet Gynecol 1994;83:113-17
61. Willemse PH, Aalders JG, Bouma J, et al. Chemotherapy-resistant gestational trophoblastic neoplasia treated successfully with cisplatin, etoposide, and bleomycin. Obstet Gynecol 1988;71:438-40
62. Lotz JP, Andre T, Donsimoni R, et al. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults. Cancer 1995;75:874-85
63. Piamsomboon S, Kudelka AP, Termrungruanglert W, et al. Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature. Eur J Gynaecol Oncol 1997;18:453-6
64. Lurain JR, Nejad B. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97:618-23
65. Wang J, Short D, Sebire NJ, et al. Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol 2008;19:1578-83
66. Clark RM, Nevadunsky N, Ghosh S, et al. The evolving role of hysterectomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med 2010;55:194-8
67. Tse KY, Chan KK, Tam KF, et al. 20-year experience of managing profuse bleeding in gestational trophoblastic disease. J Reprod Med 2007;52:397-401
68. Yingna S, Yang X, Xiuyu Y, et al. Clinical characteristics and treatment of gestational trophoblastic tumor with vaginal metastasis. Gynecol Oncol 2002;84:416-19
69. Soper JT. Surgical therapy for gestational trophoblastic disease. J Reprod Med 1994;39:168-74
70. Yang J, Xiang Y, Wan X, et al. The prognosis of gestational trophoblastic neoplasia patient with residual lung tumor after completing treatment. Gynecol Oncol 2006;103:479-82
71. Tomoda Y, Arii Y, Kaseki S, et al. Surgical indications for resection in pulmonary metastasis of choriocarcinoma. Cancer 1980;46:2723-30 (Pubitemid 11210243)
72. Fleming EL, Garrett L, Growdon WB, et al. The changing role of thoracotomy in gestational trophoblastic neoplasia at the New England Trophoblastic Disease Center. J Reprod Med 2008;53:493-8
73. Edwards JL, Makey AR, Bagshawe KD. The role of thoracotomy in the management of the pulmonary metastases of gestational choriocarcinoma. Clin Oncol 1975;1:329-39
74. Shirley RL, Goldstein DP, Collins JJ Jr. The role of thoracotomy in the management of patients with chest metastases from gestational trophoblastic disease. J Thorac Cardiovasc Surg 1972;63:545-50
75. Wang YA, Song HZ, Xia ZF, et al. Drug resistant pulmonary choriocarcinoma metastasis treated by lobectomy: report of 29 cases. Chin Med J (Engl) 1980;93:758-66
76. Sink JD, Hammond CB, Young WG Jr. Pulmonary resection in the management of metastases from gestational choriocarcinoma. J Thorac Cardiovasc Surg 1981;81:830-4
77. Lehman E, Gershenson DM, Burke TW, et al. Salvage surgery for chemorefractory gestational trophoblastic disease. J Clin Oncol 1994;12:2737-42
78. Newlands ES, Holden L, Seckl MJ, et al. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J Reprod Med 2002;47:465-71
79. Newlands ES, Bagshawe KD, Begent RH, et al. Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989. Br J Obstet Gynaecol 1991;98:550-7
80. Evans AC Jr, Soper JT, Clarke-Pearson DL, et al. Gestational trophoblastic disease metastatic to the central nervous system. Gynecol Oncol 1995;59:226-30
81. Brace K. The role of irradiation in the treatment of metastatic trophoblastic disease. Radiology 1968;91:540-4
82. Yordan EL Jr, Schlaerth J, Gaddis O, et al. Radiation therapy in the management of gestational choriocarcinoma metastatic to the central nervous system. Obstet Gynecol 1987;69:627-30
83. Grumbine FC, Rosenshein NB, Brereton HD, et al. Management of liver metastasis from gestational trophoblastic neoplasia. Am J Obstet Gynecol 1980;137:959-61
84. Wong LC, Choo YC, Ma HK. Hepatic metastases in gestational trophoblastic disease. Obstet Gynecol 1986;67:107-11
85. Jones WB, Schneider J, Shapiro F, et al. Treatment of resistant gestational choriocarcinoma with taxol: a report of two cases. Gynecol Oncol 1996;61:126-30
86. Sutton GP, Soper JT, Blessing JA, et al. Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol 1992;167:489-95
87. Osborne R, Covens A, Mirchandani D, et al. Successful salvage of relapsed high-risk gestational trophoblastic neoplasia patients using a novel paclitaxel-containing doublet. J Reprod Med 2004;49:655-61
88. Wan X, Yang X, Xiang Y, et al. Floxuridine-containing regimens in the treatment of gestational trophoblastic tumor. J Reprod Med 2004;49:453-6 (Pubitemid 38781421)
89. Matsui H, Iitsuka Y, Suzuka K, et al. Salvage chemotherapy for high-risk gestational trophoblastic tumor. J Reprod Med 2004;49:438-42 (Pubitemid 38781418)
90. Gordon AN, Kavanagh JJ, Gershenson DM, et al. Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease. Cancer 1986;58:1407-10
91. DuBeshter B, Berkowitz RS, Goldstein DP, et al. Vinblastine, cisplatin and bleomycin as salvage therapy for refractory high-risk metastatic gestational trophoblastic disease. J Reprod Med 1989;34:189-92
92. Azab M, Droz JP, Theodore C, et al. Cisplatin, vinblastine, and bleomycin combination in the treatment of resistant high-risk gestational trophoblastic tumors. Cancer 1989;64:1829-32
93. Giacalone PL, Benos P, Donnadio D, et al. High-dose chemotherapy with autologous bone marrow transplantation for refractory metastatic gestational trophoblastic disease. Gynecol Oncol 1995;58:383-5
94. van Besien K, Verschraegen C, Mehra R, et al. Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue. Gynecol Oncol 1997;65:366-9
95. Cole LA. hCG, its free subunits and its metabolites. Roles in pregnancy and trophoblastic disease. J Reprod Med 1998;43:3-10
96. Cole LA, Kohorn EI, Kim GS. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels. J Reprod Med 1994;39:193-200
97. Cole LA, Butler S. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. J Reprod Med 2002;47:433-44
98. Hancock BW. hCG measurement in gestational trophoblastic neoplasia: a critical appraisal. J Reprod Med 2006;51:859-60
99. Mitchell H, Bagshawe KD, Newlands E, et al. Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblastic disease and testicular cancer. J Reprod Med 2006;51:868-70
100. Cole LA, Kohorn EI. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers. J Reprod Med 2006;51:793-811
101. Kohorn EI. What we know about low-level hCG: definition, classification and management. J Reprod Med 2004;49:433-7
102. Hwang D, Hancock BW. Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases. J Reprod Med 2004;49:559-62
103. Khanlian SA, Cole LA. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin. J Reprod Med 2006;51:812-18
104. Mutch DG, Soper JT, Babcock CJ, et al. Recurrent gestational trophoblastic disease. Experience of the Southeastern Regional Trophoblastic Disease Center. Cancer 1990;66:978-82
105. Goldstein DP, Zanten-Przybysz IV, Bernstein MR, et al. Revised FIGO staging system for gestational trophoblastic tumors. Recommendations regarding therapy. J Reprod Med 1998;43:37-43
106. Ngan HY, Tam KF, Lam KW, et al. Relapsed gestational trophoblastic neoplasia: a 20-year experience. J Reprod Med 2006;51:829-34
107. Garrett LA, Garner EI, Feltmate CM, et al. Subsequent pregnancy outcomes in patients with molar pregnancy and persistent gestational trophoblastic neoplasia. J Reprod Med 2008;53:481-6
108. Ayhan A, Ergeneli MH, Yuce K, et al. Pregnancy after chemotherapy for gestational trophoblastic disease. J Reprod Med 1990;35:522-4
109. Kim JH, Park DC, Bae SN, et al. Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 1998;71:108-12
110. Kjer JJ, Iversen T. Malignant trophoblastic tumours in Norway. Fertility rate after chemotherapy. Br J Obstet Gynaecol 1990;97:623-5
111. Kobayashi O, Matsui H, Takamizawa H. Analysis of pregnancy outcome after chemotherapy of trophoblastic disease. Nippon Sanka Fujinka Gakkai Zasshi 1986;38:181-6 (Pubitemid 16142486)
112. Ngan HY, Wong LC, Ma HK. Reproductive performance of patients with gestational trophoblastic disease in Hong Kong. Acta Obstet Gynecol Scand 1988;67:11-14
113. Song HZ, Wu PC, Wang YE, et al. Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up. Am J Obstet Gynecol 1988;158:538-45
114. Van Thiel DH, Ross GT, Lipsett MB. Pregnancies after chemotherapy of trophoblastic neoplasms. Science 1970;169:1326-7
115. Woolas RP, Bower M, Newlands ES, et al. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynaecol 1998;105:1032-5
116. Matsui H, Iitsuka Y, Suzuka K, et al. Early pregnancy outcomes after chemotherapy for gestational trophoblastic tumor. J Reprod Med 2004;49:531-4
117. Wenzel L, Berkowitz R, Robinson S, et al. The psychological, social, and sexual consequences of gestational trophoblastic disease. Gynecol Oncol 1992;46:74-81
118. Petersen RW, Ung K, Holland C, et al. The impact of molar pregnancy on psychological symptomatology, sexual function, and quality of life. Gynecol Oncol 2005;97:535-42
119. Wenzel L, Berkowitz RS, Newlands E, et al. Quality of life after gestational trophoblastic disease. J Reprod Med 2002;47:387-94
120. Wenzel L, Berkowitz RS, Habbal R, et al. Predictors of quality of life among long-term survivors of gestational trophoblastic disease. J Reprod Med 2004;49:589-94